Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Harari

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Iscience|March 23, 2023
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinityHajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, et al.
Journal of Virology|July 22, 2011
DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosaMatthieu Perreau, Hugh C Welles, Alexandre Harari, et al.
Plos One|April 13, 2011
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCristina Cellerai, Alexandre Harari, Hans Stauss, et al.
Journal of Virology|January 23, 2015
Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteinsJulie Delaloye, Abdelali Filali-Mouhim, Mark J Cameron, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2018
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b TrialFernanda G Herrera, Massimo Valerio, Dominik Berthold, et al.
European Journal of Immunology|March 5, 2013
Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active diseaseVirginie Rozot, Selena Vigano, Jesica Mazza-Stalder, et al.
European Journal of Immunology|August 30, 2012
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patientsAlexandre Harari, Virginie Rozot, Matthias Cavassini, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
The Journal of Infection|June 15, 2023
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patientsBenedict Fallet, Mathilde Foglierini, Raphael Porret, et al.
The Journal of Experimental Medicine|April 13, 2019
Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patientsMaria A S Broggi, Lea Maillat, Cristina C Clement, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Iscience|March 23, 2023
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinityHajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, et al.
Journal of Virology|July 22, 2011
DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosaMatthieu Perreau, Hugh C Welles, Alexandre Harari, et al.
Plos One|April 13, 2011
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCristina Cellerai, Alexandre Harari, Hans Stauss, et al.
Journal of Virology|January 23, 2015
Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteinsJulie Delaloye, Abdelali Filali-Mouhim, Mark J Cameron, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2018
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b TrialFernanda G Herrera, Massimo Valerio, Dominik Berthold, et al.
European Journal of Immunology|March 5, 2013
Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active diseaseVirginie Rozot, Selena Vigano, Jesica Mazza-Stalder, et al.
European Journal of Immunology|August 30, 2012
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patientsAlexandre Harari, Virginie Rozot, Matthias Cavassini, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
The Journal of Infection|June 15, 2023
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patientsBenedict Fallet, Mathilde Foglierini, Raphael Porret, et al.
The Journal of Experimental Medicine|April 13, 2019
Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patientsMaria A S Broggi, Lea Maillat, Cristina C Clement, et al.
Pageof 13